Six-month BNT162b2 vaccine efficacy in adolescents and young adults with cancer.

Donze, Caroline; Ninove, Laetitia; de Lamballerie, Xavier; Saultier, Paul; Andre, Nicolas

Donze, Caroline; Ninove, Laetitia; de Lamballerie, Xavier; Saultier, Paul; Andre, Nicolas.

Donze C; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France.
Ninove L; Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Hôpitaux Universitaires de Marseille, Marseille, France.
de Lamballerie X; Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Hôpitaux Universitaires de Marseille, Marseille, France.
Saultier P; Department of Pediatric Hematology, Immunology, and Oncology, APHM, La Timone Children's Hospital, Marseille, France.
Andre N; INSERM, INRAe, C2VN, Aix Marseille Univ, Marseille, France.

Pediatr Blood Cancer ; 69(8): e29547, 2022 08.

Article in English | MEDLINE | ID: covidwho-1579061

Subject(s)

BNT162 Vaccine; Neoplasms; Adolescent; Humans; Neoplasms/therapy; Vaccine Efficacy; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: BNT162 Vaccine / Neoplasms Topics: Vaccines Limits: Adolescent / Adult / Humans / Young adult Language: English Journal: Pediatr Blood Cancer Journal subject: Hematology / Neoplasms / Pediatrics Year: 2022 Document Type: Article Affiliation country: Pbc.29547

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google